1. Defective CD8+CD28− regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy. (8th September 2013) Authors: Ceeraz, S.; Hall, C.; Choy, E. H.; Spencer, J.; Corrigall, V. M. Journal: Clinical and experimental immunology Issue: Volume 174:Number 1(2013:Oct.) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Enhanced and persistent levels of interleukin (IL)‐17+CD4+ T cells and serum IL‐17 in patients with early inflammatory arthritis. (6th October 2013) Authors: Gullick, N. J.; Abozaid, H. S.; Jayaraj, D. M.; Evans, H. G.; Scott, D. L.; Choy, E. H.; Taams, L. S. Journal: Clinical and experimental immunology Issue: Volume 174:Number 2(2013:Nov.) Page Start: 292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0130 Defining the Optimal Biological Monotherapy in Rheumatoid Arthritis (RA): Network Meta-Analysis of Randomized Trials. (23rd January 2014) Authors: Christensen, R.; Tarp, S.; Furst, D. E.; Østergaard, M.; Lorenzen, T.; Hansen, M. S.; Singh, J. A.; Choy, E. H.; Boers, M.; Suarez-Almazor, M. E.; Ejbjerg, B.; Kristensen, L. E.; Bliddal, H. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗